3726
I. Le Roy et al. / Tetrahedron 59 (2003) 3719–3727
and C6H4F); 4.80 (d, 1H, J¼4.64 Hz, CHcycle); 4.61 (d, 1H,
J¼4.64 Hz, CHcycle); 4.16 (m, 2H, CH2Ph); 3.95 (m, 1H,
CHcycle); 4.68 (d, 1H, J¼4.62 Hz, CHcycle); 4.07 (m, 1H,
CHCH2Ph); 3.67 (s, 3H, COOCH3); 3.27 (d, 1H,
J¼4.88 Hz, Ha in CH2); 3.03 (d, 1H, Hb in CH2); 13C
NMR (CDCl3, 50 MHz) d: 169.7 (CvO); 165.9 (CvO);
136.2 (Cipso arom); 132.4 (Cipso arom); 129, 128, 127 (CH
arom); 121 (CH arom); 115 (CH arom); 81.4 (CHCH2); 63.5
(CHcycle); 56.6 (CHcycle); 52.5 (CH3); 35.9 (CH2); GC tR
39.1 min; calcd for C25H23NO4 C, 74.79; H, 5.77; N, 3.48;
found C, 74.44; H, 5.88; N, 3.21.
CHCH2); 3.68 (s, 3H, COOCH3); 3.20 (d, 2H, CHCH2); 13
C
NMR (CDCl3, 50 MHz) d: 133 (Cipso arom); 132 (Cipso
arom); 131, 130, 129, 128 (CH arom); 116, 115 (CH in
C6H4F); 83.3 (CHCH2); 72.4 (CH2Ph); 63.4 (CHcycle); 58
(CHcycle); 52.6 (CH3); 35.3 (CH2). NMR 19F(CDCl3,
94.2 MHz) d: 2115.9; 2116.0; GC tR 40.6 min; MS: 91
(100), 109 (13), 210 (19), 286 (11), 433 (0.8); calcd for
C26H24NFO4 C, 72.04; H, 5.58; N, 3.23; found C, 71.99; H,
5.60; N, 3.15.
4.15. Solid phase (Merrifield or Wang resins) procedure
for the synthesis of b-lactams
4.14.4. cis-Methyl (3-benzyloxy-2-oxo-4-phenyl-azetidin-
1-yl)-phenyl acetate 37a-b. Major isomer: (67%); 1H NMR
(CDCl3, 200 MHz) d: 7.35–6.89 (m, 10H, 2 C6H5); 5.5 (s,
1H, CHPh); 5.09 (d, 1H, J¼4.57 Hz, CHcycle); 4.95 (d, 1H,
J¼4.55 Hz, CHcycle); 4.15 (m, 2H, CH2Ph); 3.71 (s, 3H,
COOCH3); 13C NMR (CDCl3, 50 MHz) d: 169 (CvO); 167
(CvO); 136 (Cipso arom); 132 (Cipso arom); 129, 128, 127
(CH arom); 83.2 (CHPh); 72 (CH2Ph); 62.8 (CHcycle); 58.2
(CHcycle); 52.7 (CH3); GC tR 38.3 min; minor isomer:
(33%); 1H NMR (CDCl3, 200 MHz): d: 7.35–6.89 (m, 10H,
2 C6H5); 5.32 (s, 1H, CHPh); 4.82 (d, 1H, J¼4.66 Hz,
CHcycle); 4.63 (d, 1H, J¼4.64 Hz, CHcycle); 4.08 (m, 2H,
CH2Ph); 3.54 (s, 3H, COOCH3); NMR 13C (CDCl3,
50 MHz) d: 168.8 (CvO); 166.9 (CvO); 136 (Cipso
arom); 134 (Cipso arom); 129, 128, 127 (CH arom); 83.0
(CHPh); 72.3 (CH2Ph); 63.1 (CHcycle); 59.6 (CHcycle); 52.5
(CH3); GC tR 38.6 min.
To the Merrifield-imine resin (23 or 24, 0.2 mmol) or Wang-
imine resin (35, 0.2 mmol) swelled in CH2Cl2 (5 mL) was
added slowly, at 2788C, Et3N (560 mL, 4 mmol), and
dropwise, the substituted acid chloride R3CH2COCl
(benzyloxyacetyl chloride or phenoxyacetyl chloride,
3 mmol). The reaction was mixed at room temperature for
18 or 24 h, then filtered. The resin was washed with DMF
(2£15 mL), CH2Cl2 (2£15 mL), MeOH (2£15 mL), Et2O
(2£15 mL), CH2Cl2 (20 mL), and dried in vacuo, to provide
resins Merrifield-b-lactam-resin 29, 30 and 31, or Wang-b-
lactam-resin 35 analyzed by NMR 19F (CDCl3, 94.2 MHz)
d: 29 2115.58 and 2115.6; 30 2115.3 and 2115.6; 31
2115.8 and 2116.1; 35 2115.8 and 2116.0.
4.16. General procedure for recovery and analysis of
b-lactams from Merrifield resins
4.14.5. cis-Methyl 2-(3-benzyloxy-2-oxo-4-phenyl-azeti-
din-1-yl)-3-phenyl propionate 38a-b. Major isomer:
(58%); 1H NMR (CDCl3, 200 MHz) d: 7.30–6.85 (m,
15H, 3 C6H5); 4.79 (d, 1H, J¼4.64 Hz, CHcycle); 4.69 (d,
1H, J¼4.64 Hz, CHcycle); 4.09 (m, 3H, CHCH2 and
CH2Ph); 3.62 (s, 3H, COOCH3); 3.30 (d, 2H, J¼5.12 Hz,
CHCH2); 13C NMR (CDCl3, 50 MHz) d: 169.9 (CvO);
167.6 (CvO); 137, 136, 133 (Cipso arom); 129, 128, 127
(CH arom); 83 (CHCH2); 72.1 (CH2Ph); 62.7 (CHcycle);
58.3 (CHcycle); 52 (CH3); 35 (CH2); GC tR 39.7 min; minor
To the Merrifield-b-lactam-resin (29, 30 or 31, 150 mg,
0.180 mmol) swelled in a 1:4 MeOH/THF solution (v:v,
6 mL) was added a 1 M solution of NaOMe in MeOH
(40 mL) and the suspension was mixed at room temperature
18 h. The resin was filtered, washed with 1:1 solution of
MeOH/THF (v:v, 40 mL), THF (40 mL), MeOH (40 mL),
and CH2Cl2 (40 mL). The combined organic washes were
evaporated, after drying, to provide the crude b-lactams
analyzed by GC and NMR. For 1H and 19F NMR, see above.
GC 32a-b: (61 mg, 81%) 73:27 tR 38.6 and 39.1 min; 33a-b:
(63 mg, 87%) 77:23 tR 37.3 and 37.6 min; 34a-b: (53 mg,
68%) 67:33 tR 39.8 and 40.6 min.
1
isomer: (42%); H NMR (CDCl3, 200 MHz) d: 7.30–6.85
(m, 15H, 3 C6H5); 4.78 (d, 1H, J¼4.62 Hz, CHcycle); 4.50 (d,
1H, J¼4.62 Hz, CHcycle); 4.09 (m, 3H, CHCH2 and
CH2Ph); 3.67 (s, 3H, COOCH3); 3.23 (d, 2H, J¼5.12 Hz,
CHCH2); 13C NMR (CDCl3, 50 MHz) d: 169.8 (CvO);
167.1 (CvO); 137, 136, 134 (Cipso arom); 129, 128, 127
(CH arom); 83 (CHCH2); 72.3 (CH2Ph); 63.4 (CHcycle);
56.5 (CHcycle); 52 (CH3); 36 (CH2); GC tR 40.0 min; calcd
for C26H25NO4: C, 75.16; H, 6.06; N, 3.37; found C, 74.92;
H, 6.26; N, 3.17.
4.17. Cleavage of cycloadducts from Wang resin
4.17.1. By TFA treatment and esterification. The resin
35 (150 mg, 0.15 mmol) was treated with a 5% solution of
TFA in H2O (7.5 mL) and the suspension shaken for 1.5 h
at room temperature. The resin was filtered and washed
with CH2Cl2 (2£20 mL). Filtration and evaporation in
vacuo produced an oily residue (50 mg) to which SOCl2
(16 mL) was added in MeOH (5 mL), and the mixture
was then refluxed for 18 h. Concentration in vacuo
afforded 25 mg (38%) of 34a-b GC 65:35 tR 39.8 and
40.6 min.
4.14.6. cis-Methyl 2-(3-phenoxy-2-oxo-4-phenyl-azeti-
din-1-yl)-3-phenyl propionate 39a-b. Major isomer:
1
(55%); H NMR (CDCl3, 200 MHz) d: 6.95 (m, 15H, 3
C6H5); 5.34 (d, 1H, CHcycle); 4.88 (d, 1H, J¼4.88 Hz,
CHcycle); 4.07 (m, 1H, CHCH2Ph); 3.62 (s, 3H, COOCH3);
3.34 (d, 1H, J¼5.14 Hz, Ha in CH2); 3.02 (d, 1H, Hb in
CH2); 13C NMR (CDCl3, 50 MHz) d: 169.6 (CvO); 166.4
(CvO); 136.8 (Cipso arom); 133.2 (Cipso arom); 129, 128,
127 (CH arom); 121 (CH arom); 115 (CH arom); 81.6
(CHCH2); 62.7 (CHcycle); 58.5 (CHcycle); 52.6 (CH3); 35.3
4.17.2. By MeONa/MeOH treatment. To a suspension of
resin 35 (150 mg, 0.15 mmol) in a 1:4 solution of MeOH/
THF (5 mL) was added a 1 M solution of NaOMe in MeOH
(22 mL) and the mixture was shaken for 18 h at room
temperature. The resin was separated by filtration, washed
with THF (20 mL), MeOH (20 mL), and CH2Cl2 (20 mL).
The combined organic washes were dried, evaporated, and
1
(CH2); GC tR 38.8 min; minor isomer: (45%); H NMR
(CDCl3, 200 MHz) d: 6.95 (m, 15H, 3 C6H5); 5.31 (d, 1H,